跳至主要内容
临床试验/2024-515328-35-00
2024-515328-35-00招募中4 期

Temporal characterization of Extracellular Vesicles during cellular therapy using CAR-T cells and during the occurrence of Immune effector Cell-Associated Neurotoxicity Syndrome : the VESICANS study

Centre Hospitalier Universitaire De Saint Etienne1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年9月10日最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
60
试验地点
1
主要终点
Quantification and characterization endothelial EVs.

研究概览

简要总结

Describe the characteristics of endothelial EVs and their temporal evolution before and after treatment with CAR-T cells according to ICANS grade.

研究设计

分配方式
Not Applicable
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 years 至 65+ years(18-64 Years, 65+ Years)
接受健康志愿者

入选标准

  • Patient over 18 years old
  • Patients for whom CAR-T treatment of their disease is indicated
  • Patient affiliated to or entitled under a social security scheme
  • Patient has received informed consent to participate in the study and has co-signed a consent form with the investigator.

排除标准

  • Pregnant or breast-feeding woman
  • Patient unable to understand informed consent
  • Patient deprived of liberty or under legal protection (guardianship, curatorship, safeguard of justice, family habilitation).
  • Contraindication to MRI
  • Contraindication to contrast product

结局指标

主要结局

Quantification and characterization endothelial EVs.

Quantification and characterization endothelial EVs.

次要结局

  • Quantification and characterization of other EVs subtypes as a function of time before and after treatment with CAR-T cells according to ICANS grade.
  • Quantification and characterization of EVs according to the presence of an ICANS versus no ICANS.
  • Quantification and characterization of EVs according to levels of cytokines.
  • Quantification and structural and molecular characterization of EVs after treatment with CAR-T cells in cerebrospinal fluid (CSF) if available.
  • Characterization of the association of subpopulations of EVs according to clinical neurological impairment and the presence or absence of a sleep apnea syndrome.
  • Characterization of the association of EVS subpopulations according to cognitive assessment and MRI before lymphodepleting chemotherapy and at the time of ICANS.
  • Description of involvement on MRI before lymphodepleting chemotherapy and at the time of ICANS.

研究者

申办方类型
Hospital/Clinic/Other health care facility
责任方
Principal Investigator
主要研究者

Project manager

Scientific

Centre Hospitalier Universitaire De Saint Etienne

研究点 (1)

Loading locations...

相似试验